BioSpace News Archive

Joel M. Androphy and Sarah M. Frazier of the Berg & Androphy law firm, along with the State of Texas and other law firms, have reached settlements in Texas Medicaid Fraud Prevention Act litigation against AstraZeneca.

Seqirus has started to ship its portfolio of more than 50 million doses of influenza vaccines to the U.S. market in preparation for the upcoming 2018-2019 influenza season

DNAlite Therapeutics, Inc., an early stage preclinical therapeutic company has raised $1.5 million in a seed-stage financing. DNAlite was founded by UC Berkeley graduates Mubhij Ahmad and Timothy Day in 2016.

Further strengthens BioAxone’s patent portfolio for Rho Kinase 2 inhibitors

The program recognizes over 30 exceptional pharmacy professionals in 10 categories

Cook Medical has introduced the 140 mm-length Zilver® PTX® Drug-Eluting Peripheral Stent in both 6 and 7 mm diameters in the U.S.

Agilent Technologies Inc. (NYSE: A) announced today the release of a new version of its chromatography data system that enables laboratories to export files in the Allotrope Data Format (ADF), an emerging standard developed by a consortium of pharmaceutical companies.

Lixte Biotechnology Holdings, Inc. announced the appointments of two new members to the Board of Directors of Lixte: Yun Yen, MD, PhD and Winson (Sze Chun) Ho, MD.

Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in previously treated patients based on data showing improved progression-free survival (PFS) and overall response rate (ORR) when compared to vorinostat.

Teneobio, Inc., a next generation multi-specific antibody therapeutics company, and Poseida Therapeutics, Inc., a San Diego-based clinical-stage company translating best-in-class gene engineering technologies into lifesaving cell therapies, announced today a new research collaboration and licensing agreement to develop novel CAR-T therapies using Teneobio’s heavy chain only domain antibodies (UniDabs™).